Therapeutic efficacy of dendritic cell vaccine combined with programmed death 1 inhibitor for hepatocellular carcinoma.
Chiao-Fang TengTing WangFu-Ying ShihWoei-Cherng ShyuLong-Bin JengPublished in: Journal of gastroenterology and hepatology (2021)
Our results suggest that a combination treatment with DC vaccine and PD-1 inhibitor may be a promising therapeutic strategy for HCC.